ALG13 and epilepsy: All have a de novo mutation, infantile spasms, developmental and epileptic encephalopathy, drug‐resistant epilepsy, intellectual disability, dysmorphic findings, recurrent infections, skeletal anomalies, brain abnormalities and a movement disorder: a phenotype not consistently reported in males with other pathogenic variants in ALG13.